This inventor holds 1 USPTO granted patent. Top assignee: Core Blood Registry, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Thomas Eldon Moore: Innovator in Stem Cell Registry Technology
Introduction
Thomas Eldon Moore is a notable inventor based in Los Altos Hills, California. He has made significant contributions to the field of stem cell technology, particularly through his innovative patent related to cord stem cells. His work aims to enhance the accessibility and utility of stem cells for families in need.
Latest Patents
Moore holds a patent for a "Computer-based mixed-use registry of placental and umbilical cord stem." This invention provides a system, method, and device for developing and maintaining a mixed-use bank of placental and umbilical cord stem cells. The registry allows for the storage of cord stem cells for potential use by the donor and their family, as well as for unrelated individuals who may require a match. The system ensures that families have the option to retain the sample or provide it to a non-family member in need.
Career Highlights
Moore is currently associated with Core Blood Registry, Inc., where he applies his expertise in stem cell technology. His work at the company focuses on advancing the field of cord blood banking and improving the processes involved in stem cell storage and retrieval.
Collaborations
Some of his notable coworkers include David T Harris and Jesse O Kramer. Their collaboration contributes to the innovative environment at Core Blood Registry, Inc., fostering advancements in stem cell research and applications.
Conclusion
Thomas Eldon Moore's contributions to the field of stem cell technology through his innovative patent and work at Core Blood Registry, Inc. highlight his commitment to improving healthcare solutions. His efforts in developing a mixed-use registry for cord stem cells represent a significant advancement in the accessibility of stem cell resources.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile